Home | Institute of Molecular and Translational Medicine

IMTM REACTOR 2023

The 7th IMTM REACTOR / October 2–4, 2023 / hotel Lanterna in Velké Karlovice – The conference will be focused on the recent develompent of IMTM and related laboratories. It should serve to connect and strenghten inter-laboratory collaboration within the Institute.

ONKO PACIENT 2023

October 5, 2023 / Old Town Hall, Prague, CZ – A patient conference focused on the latest findings in the field of cancer prevention, diagnosis and treatment research. The leading Czech experts in cancer research and treatment will participate the conference.

Czech Annual Cancer Research Meeting 2023

November 20-22, 2023 / Olomouc, CZ — Czech Annual Cancer Research Meeting program will cover the latest topics in cancer research, molecular pathology and predictive oncology.

More info

News

Mendel-Zirm Lecture Series: Maryam Nikkhah, PhD. and Saman Hosseinkhani, PhD. – Visualization and Targeting Protein Complexes in Cell Death

Monday, September 11, 2023

Wednesday, September 13, 2023 / 1:00 PM MTM Seminary room 1.09

Read article

Lukáš Najdekr Ph.D. will be participating as a lecturer at the FEBS Advanced courses at the University of Liverpool

Tuesday, August 29, 2023

The course focuses on a general application of metabolomics in biological systems

Read article

IMTM REACTOR 2023

Monday, August 28, 2023

7th Annual IMTM Retreat / October 2–4, 2023 / Velké Karlovice, CZ

Read article

PERMED: T2BA Consortium meeting / T2BA Scientific board meeting (NCC Council)

Monday, June 12, 2023

June 22–23,2023 / Seminary room 1.09

Read article

Lecture: Assoc. prof. RNDr. Daniel Smrž, Ph.D. — Cellular immunotherapy in the treatment of solid tumors – from benchtop to clinical applications

Tuesday, May 16, 2023

Friday, May 19, 2023 / 10:00 AM / Seminary room 1.09

Read article

News archive

Tweets by IMTM_Olomouc

IMTM YouTube channel

YouTube Channel

Featured publications

MAYA-MENDOZA, A., P. MOUDRÝ, J. MERCHUT-MAYA, M. LEE, R. STRAUSS, J. BÁRTEK

High speed of fork progression induces DNA replication stress and genomic instability. Nature. 2018, 559(7713), 279-284, ISSN: 0028-0836, IF: 41.577, PMID: 29950726.

ŠKROTT, Z., M. MISTRÍK, K. ANDERSEN, S. FRIIS, D. MAJERA, J. GURSKÝ, T. OŽDIAN, J. BARTKOVA, Z. TURI, P. MOUDRÝ, M. KRAUS, M. MEDVEDÍKOVÁ, J. VÁCLAVKOVÁ, P. DŽUBÁK, I. VROBEL, P. POUCKOVA, J. SEDLACEK, A. MIKLOVICOVA, A. KUTT, J. MATTOVA, C. DRIESSEN, Q. DOU, J. OLSEN, M. HAJDÚCH, B. CVEK, R. DESHAIES, J. BÁRTEK

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017, 552(7684), 194-199, ISSN: 0028-0836, IF: 40.137, PMID: 29211715.

VAN GOOL, A., F. BIETRIX, E. CALDENHOVEN, K. ZATLOUKAL, A. SCHERER, J. LITTON, G. MEIJER, N. BLOMBERG, A. SMITH, B. MONS, J. HERINGA, W. KOOT, M. SMIT, M. HAJDÚCH, T. RIJNDERS, A. USSI

Bridging the translational innovation gap through good biomarker practice. Nature Reviews. Drug Discovery. 2017, 16(9), 587-588, ISSN: 1474-1776, IF: 57.000, PMID: 28450744.

GILLILAND, C., D. ZUK, P. KOCIS, M. JOHNSON, S. HAY, M. HAJDÚCH, F. BIETRIX, G. AVERSA, C. AUSTIN, A. USSI

Putting translational science on to a global stage. Nature Reviews Drug Discovery. 2016, 15, 217-219, ISSN: 1474-1776, IF: 57.000, PMID: 27032820.

DIETLEIN, F., B. KALB, M. JOKIC, E. NOLL, A. STRONG, L. THARUN, L. OZRETIC, H. KUNSTLINGER, K. KAMBARTEL, W. RANDERATH, C. JUNGST, A. SCHMITT, A. TORGOVNICK, A. RICHTERS, D. RAUH, F. SIEDEK, T. PERSIGEHL, C. MAUCH, J. BARTKOVA, A. BRADLEY, M. SPRICK, A. TRUMPP, R. RAD, D. SAUR, J. BÁRTEK, J. WOLF, R. BUTTNER, R. THOMAS, H. REINHARDT

A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer. Cell. 2015, 162(1), 146-159, ISSN: 0092-8674, IF: 28.710, PMID: 26140595.

XU, G., J. CHAPMAN, I. BRANDSMA, J. YUAN, M. MISTRÍK, P. BOUWMAN, J. BARTKOVA, E. GOGOLA, D. WARMERDAM, M. BAZARAS, J. JASPERS, K. WATANABE, M. PIETERSE, K. KERSBERGEN, W. SOL, P. CELIE, P. SCHOUTEN, B. VAN DEN BROEK, A. SALMAN, M. NIEUWLAND, I. DE RINK, J. DE RONDE, K. JALINK, S. BOULTON, J. CHEN, D. VAN GENT, J. BÁRTEK, J. JONKERS, P. BORST, S. ROTTENBERG

REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature. 2015, 521(7553), 541-544, ISSN: 0028-0836, IF: 38.138, PMID: 25799992.

All Publications